Nasdaq Markets

Image source: Getty Images

In recent trading, shares of LHC Group Inc (Symbol: LHCG) have crossed above the average analyst 12-month target price of $207.00, changing hands for $208.18/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on va

In recent trading, shares of Repligen Corp. (Symbol: RGEN) have crossed above the average analyst 12-month target price of $149.57, changing hands for $150.87/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v

In recent trading, shares of Amedisys, Inc. (Symbol: AMED) have crossed above the average analyst 12-month target price of $237.75, changing hands for $238.67/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v

In recent trading, shares of MongoDB Inc (Symbol: MDB) have crossed above the average analyst 12-month target price of $213.90, changing hands for $219.80/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valua

In recent trading, shares of Bandwidth Inc (Symbol: BAND) have crossed above the average analyst 12-month target price of $155.12, changing hands for $157.56/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on va

In recent trading, shares of Thomson Reuters Corp (Symbol: TRI) have crossed above the average analyst 12-month target price of $76.45, changing hands for $76.92/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade o

Microsoft (NASDAQ: MSFT) and Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) are two tech giants that frequently find themselves in competition with one another. Microsoft founder Bill Gates said that beating Android in the mobile computing market was a "$400 billion mistake" he regrets

Cannabis giant Aurora Cannabis (NYSE: ACB) hasn't announced a date for its fourth-quarter earnings release just yet, but it will likely arrive in September, as it did last year. It'll be an important finish to what's been a challenging year for the Alberta, Canada-based cannab

(RTTNews) - French stocks were little changed in directionless trade on Friday after a survey highlighted the fragility of demand conditions faced by French businesses and cast further doubt over the V-shaped recovery.

(RTTNews) - German stocks edged higher on Friday after a survey showed German manufacturing continued to improve in August in terms of trends in output and new orders.

(RTTNews) - Asian stocks rose broadly on Friday as news that China and the U.S. have agreed to hold new trade talks in the coming days helped offset gloom over downbeat U.S. jobless claims data released overnight.

(RTTNews) - Retailers Target Inc. and Aldi are recalling peaches after they were linked to multistate outbreak of Salmonella Enteritidis infection that sickened at least 68 people in nine states.

(RTTNews) - Hg, the Manager of HgCapital Trust plc, announced that the Hg Saturn team and its investors have agreed to a further investment in Visma, a provider of business-critical software to private and public enterprises in the Nordic, Benelux and Baltic regions. Hg will put

(RTTNews) - AstraZeneca Plc (AZN.L, AZN) announced Friday that its Imfinzi (durvalumab) has been approved in Japan for the treatment of patients with extensive-stage small cell lung cancer or ES-SCLC.

(RTTNews) - European stocks look set to open a tad higher on Friday after China said it has agreed to hold talks with U.S. officials soon to review progress on their preliminary deal.

Image source: The Motley Fool.

(RTTNews) - Indian shares opened higher on Friday, tracking overnight gains in U.S. indexes and positive Asian shares on bets that tech giants such as Apple Inc, Amazon.com Inc and Microsoft Corp would ride out the economic crisis.

(RTTNews) - Asian stock markets are mostly higher on Friday following the tech-driven rally overnight on Wall Street and on news that China and the U.S. have agreed to hold new trade talks in the coming days.

(RTTNews) - Amgen (AMGN) said that the U.S. Food and Drug Administration has approved the expansion of the KYPROLIS or carfilzomib U.S. prescribing information to include its use in combination with DARZALEX or daratumumab plus dexamethasone or DKd in two dosing regimens — onc